Keyphrases
Acute Lymphoblastic Leukemia
86%
Chemotherapy
67%
Risk Factors
64%
Transfusion-dependent Thalassemia
64%
Pediatric Acute Lymphoblastic Leukemia
53%
Childhood Acute Lymphoblastic Leukemia
45%
Thalassemia
45%
Induction Period
34%
General Hospital
27%
Serum Ferritin
26%
Blood Transfusion
24%
Standard Risk
22%
Transfusion
19%
L-asparaginase
19%
Indonesia
18%
Iron Chelation
17%
Pediatric Leukemia
16%
Platelet Refractoriness
16%
Corrected Count Increment
16%
Platelet Concentrate Transfusion
16%
Pediatric Oncology
16%
CD26
16%
Laboratory Effects
16%
Acute Lymhoblastic Leukemia
16%
Cardiotoxicity
16%
Lymphocyte-to-monocyte Ratio
16%
Sepsis Mortality
16%
Hematology
16%
Body Segment
16%
Bcl-2 Family Proteins
16%
Function Features
16%
High-dose Methotrexate (HD-MTX)
16%
Pediatric Transfusion
16%
Hyperleukocytosis
16%
Clinical Effect
16%
Neutrophil-to-lymphocyte Ratio
16%
Quality of Life
16%
East Java Indonesia
16%
Protein Expression
16%
Renal Function
16%
Methotrexate Chemotherapy
16%
Hepatotoxicity
16%
Growth Status
16%
Mean Platelet Volume
16%
Community-acquired Pneumonia
16%
Alloimmunization
16%
Autoimmunization
16%
Platelet-to-lymphocyte Ratio
16%
β-Thalassemia (β-thal)
16%
Ketorolac
16%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Pediatrics
88%
Leukemia
48%
Platelet
36%
Hematology
33%
Leukocyte
25%
Lymphocyte
22%
Childhood Cancer
20%
Neutrophil
19%
Thrombocyte Transfusion
16%
Sepsis
16%
Hospital-Acquired Pneumonia
16%
Induction Chemotherapy
16%
Mean Platelet Volume
16%
Protein Bcl 2
16%
Protein Expression
16%
Quality of Life
16%
Exchange Blood Transfusion
16%
Retrospective Study
16%
Liposomal Daunorubicin
16%
Cardiotoxicity
16%
Tumor Lysis Syndrome
16%
Solid Malignant Neoplasm
16%
Burkitt's Lymphoma
16%
Ferritin
16%
Blood Transfusion
16%
Thalassemia
16%
High Risk Population
12%
Cell Count
10%
Anthracycline
9%
Lymphoblast
8%
Pallor
8%
Hepatomegaly
8%
Dyspnea
8%
Cerebral Hemorrhage
8%
Lymphadenopathy
7%
Acute Lymphocytic Leukemia
7%
Blood Glucose
6%
Heart Left Ventricle Ejection Fraction
6%
Outpatient
6%
Eosinophil
6%
Malignant Neoplasm
6%
Neutropenia
6%
Diseases
6%
Risk Stratification
6%
Survival Rate
5%
Bone Marrow Biopsy
5%
Wilcoxon Signed Ranks Test
5%
Lactate Dehydrogenase
5%
Pediatrics Patient
5%
